首页> 美国卫生研究院文献>British Journal of Clinical Pharmacology >Beta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma.
【2h】

Beta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma.

机译:β-肾上腺素能受体对支气管哮喘患者大剂量吸入沙丁胺醇的反应。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. Fourteen asthmatics (mean +/- s.e. mean baseline FEV1 62 +/- 6% of predicted) were given cumulative doubling doses of salbutamol by metered-dose inhaler as follows: 100 micrograms, 200 micrograms, 500 micrograms, 1000 micrograms, 2000 micrograms, 4000 micrograms. 2. Airways, tremor, haemodynamic and cyclic AMP responses were measured at each dose increment (made every 20 min). 3. There was a linear log dose-response relationship for each airways parameter (FEV1, VC, sGaw, FEF 50%). The plateau in the dose-response curve was not reached within our dose range. These changes were also mirrored in cyclic AMP responses. 4. There was a wide range in maximum airways response expressed in terms of absolute increase over baseline (95% confidence intervals: delta FEV1 667-1483 ml; delta VC 689-1695 ml; delta sGaw 0.92-4.50 s-1 kPa-1; delta FEF 50% 0.94-2.15 l s-1). Patients with a lower baseline showed a greater response in terms of percent increase in FEV1 (r = -0.83, P less than 0.001). There was however, no correlation between baseline airway calibre and the dose required for maximum bronchodilatation. 5. There were objective increases (mean +/- s.e. mean) in both heart rate (maximum delta HR of 14 +/- 5 beats min-1 at 4000 micrograms) and tremor power (maximum delta Tr of 115 +/- 44% at 2000 micrograms). These were not dose limiting side-effects as subjective symptoms were infrequent at higher doses. 6. Higher than conventional doses of salbutamol given by metered-dose inhaler may produce a distinct improvement in airways response without significant side-effects.(ABSTRACT TRUNCATED AT 250 WORDS)
机译:1.通过计量吸入器向沙丁胺醇累积加倍剂量的十四种哮喘病患者(平均基线FEV1平均基线FEV1为预测值的62 +/- 6%),分别为:100微克,200微克,500微克,1000微克,2000年微克,4000微克2.在每次剂量增加时(每20分钟进行一次)测量气道,震颤,血流动力学和循环AMP反应。 3.每个气道参数(FEV1,VC,sGaw,FEF 50%)之间存在线性对数剂量-响应关系。在我们的剂量范围内,未达到剂量反应曲线的平稳期。这些变化也反映在循环AMP响应中。 4.最大气道反应范围广泛,以相对于基线的绝对增加表示(95%置信区间:delta FEV1 667-1483 ml; delta VC 689-1695 ml; delta sGaw 0.92-4.50 s-1 kPa-1 ; FEF增量50%0.94-2.15 l s-1)。基线较低的患者在FEV1增加百分比方面表现出更大的反应(r = -0.83,P小于0.001)。但是,基线气道口径与最大支气管扩张所需剂量之间没有相关性。 5.心率(4000微克时的最大德尔塔HR为14 +/- 5次心跳min-1)和震颤力(最大德尔塔Tr为115 +/- 44%)均有客观增加(平均值+/- se平均值)在2000微克)。这些不是剂量限制的副作用,因为高剂量时主观症状很少见。 6.定量吸入器给予沙丁胺醇的剂量高于常规剂量可能会显着改善气道反应,而无明显副作用。(摘要截断为250字)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号